Hunt Nimrata 4
4 · IDEXX LABORATORIES INC /DE · Filed Feb 17, 2026
Research Summary
AI-generated summary of this filing
IDEXX (IDXX) EVP Nimrata Hunt Exercises RSUs, Sells 1,154 Shares
What Happened
- Nimrata Hunt, Executive Vice President of IDEXX Laboratories (IDXX), had multiple equity awards and conversions around February 12–14, 2026. On Feb 12 she received grants (derivative awards) totaling 7,501 restricted stock units (RSUs). On Feb 14 she exercised/converted derivative awards into 2,587 shares (several conversion entries).
- To cover tax withholding/obligations tied to those transactions, 1,154 shares were disposed (sold) at $629.35 per share, generating $726,270. Several other conversion entries are recorded with $0 proceeds (typical for RSU conversions where no cash changes hands).
Key Details
- Transaction dates: Grants on 2026-02-12; conversions/exercises and sell-to-cover on 2026-02-14. Form 4 filed 2026-02-17.
- Key amounts: Grants = 7,501 RSUs (derivative awards). Conversions/exercises acquired = 2,587 shares. Shares sold for tax withholding = 1,154 at $629.35 each, proceeds $726,270.
- Footnotes of note:
- F10/F11: RSUs — some awards vest beginning Feb 14, 2026 (some vest immediately in one installment, others vest in annual installments).
- F1: ESPP holding detail — includes 10 shares purchased on Dec 31, 2025; ESPP balance shown as 401.944 shares (includes small fractional adjustment).
- F (tax withholding): the 1,154-share disposal is for payment of tax liability (sell-to-cover).
- Shares owned after transaction: Not specified in the provided excerpt of the filing.
- Timing: Form 4 was filed Feb 17, 2026. The filing does not indicate a late-reporting flag in the provided data.
Context
- These entries are primarily grants and RSU conversions (derivative transactions). When RSUs vest/convert, companies commonly withhold or sell shares to satisfy required tax withholdings — that appears to be what occurred here (a sell-to-cover of 1,154 shares).
- This filing shows routine executive equity compensation activity (awards + tax-withholding sale) rather than an open-market purchase or discretionary sale; it should be interpreted as compensation-related, not necessarily a direct signal of the insider’s view of the stock.
Insider Transaction Report
Form 4
Hunt Nimrata
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-14+204→ 21,362.944 total - Exercise/Conversion
Common Stock
2026-02-14+207→ 21,569.944 total - Exercise/Conversion
Common Stock
2026-02-14+301→ 21,870.944 total - Exercise/Conversion
Common Stock
2026-02-14+1,508→ 23,378.944 total - Exercise/Conversion
Common Stock
2026-02-14+367→ 23,745.944 total - Tax Payment
Common Stock
[F2]2026-02-14$629.35/sh−1,154$726,270→ 22,591.944 total - Award
Non-Qualified Stock Option (right-to-buy)
[F3]2026-02-12+4,625→ 4,625 totalExercise: $617.20Exp: 2036-02-11→ Common Stock (4,625 underlying) - Award
Incentive Stock Option (right-to-buy)
[F4]2026-02-12+162→ 162 totalExercise: $617.20Exp: 2036-02-11→ Common Stock (162 underlying) - Award
Restricted Stock Unit
[F5]2026-02-12+1,094→ 1,094 total→ Common Stock (1,094 underlying) - Award
Restricted Stock Unit
[F6]2026-02-12+1,620→ 1,620 total→ Common Stock (1,620 underlying) - Exercise/Conversion
Restricted Stock Unit
[F7]2026-02-14−204→ 0 total→ Common Stock (204 underlying) - Exercise/Conversion
Restricted Stock Unit
[F8]2026-02-14−207→ 207 total→ Common Stock (207 underlying) - Exercise/Conversion
Restricted Stock Unit
[F9]2026-02-14−301→ 602 total→ Common Stock (301 underlying) - Exercise/Conversion
Restricted Stock Unit
[F10]2026-02-14−367→ 1,101 total→ Common Stock (367 underlying) - Exercise/Conversion
Restricted Stock Unit
[F11]2026-02-14−1,508→ 0 total→ Common Stock (1,508 underlying)
Holdings
- 160(indirect: By Spouse)
Common Stock
Footnotes (11)
- [F1]1. Includes 10 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on December 31, 2025. There are a total of 401.944 shares held in the ESPP which has been increased by 0.005 shares due to a rounding calculation of previously issued fractional shares.
- [F10]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026.
- [F11]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in one installment on February 14, 2026.
- [F2]Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.
- [F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.
- [F4]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.
- [F5]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock that vests in four annual installments, beginning February 14, 2027.
- [F6]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in three annual installments, beginning February 14, 2027.
- [F7]Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023.
- [F8]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
- [F9]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Nimrata Hunt|2026-02-17